Literature DB >> 32167429

Do We Have Another Option to Treat Bleeding Hemorrhoids? The Emborrhoid Technique: Experience in 16 Patients.

Elisabetta Moggia1, Giuseppina Talamo2, Gaetano Gallo3, Angelo Bianco4, Matteo Barattini5, Giancarlo Salsano5, Daniele Zefiro6, Teseo Stefanini5, Stefano Berti4.   

Abstract

BACKGROUND: Hemorrhoidal disease is very common in western countries and rectal bleeding is the main symptom complained by patients. Nowadays the ultimate goal of treatment is to block the bleeding with minimally-invasive techniques to minimize post-procedural pain.
OBJECTIVE: The aim of this study is to assess the preliminary results of the emborrhoid technique (embolization of the superior rectal arteries branches) as a new tool for the proctologist to treat severe bleeding hemorrhoids causing anemia. Many categories of patients might benefit from this treatment, such as patients not eligible for conventional surgery, patients not responding to conventional treatment and fit patients with severe bleeding who refused endorectal surgical therapy.
METHODS: From May 2017 to November 2018 a total of 16 patients with chronic rectal bleeding due to hemorrhoids underwent super-selective embolization of the superior rectal arteries at the department of General Surgery in La Spezia, S. Andrea Hospital, Italy. Median age was 59 years. 14 patients were males (87.5%).
RESULTS: No post-procedural and short-term complications were observed at maximum follow up (12 months). The reduction of rectal bleeding with improvement of the quality of life was obtained in 14 patients (87.5%).
CONCLUSION: Our study, although small in number, demonstrates that embolization of superior rectal arteries with coils to treat severe bleeding due to hemorrhoids is safe and effective and does not lead to immediate complications. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Embolization; bleeding hemorrhoids; endovascular coils; hemorrhoidal disease; interventional radiology; superior rectal artery branches

Year:  2021        PMID: 32167429     DOI: 10.2174/1574887115666200313102246

Source DB:  PubMed          Journal:  Rev Recent Clin Trials        ISSN: 1574-8871


  6 in total

Review 1.  Emborrhoid: Rectal Artery Embolization for Hemorrhoid Disease.

Authors:  Julien Panneau; Diane Mege; Mathieu Di Biseglie; Julie Duclos; Paul Habert; Vincent Vidal; Farouk Tradi
Journal:  Semin Intervent Radiol       Date:  2022-06-30       Impact factor: 1.780

2.  Clinical Outcomes Following Rectal Artery Embolisation for the Treatment of Internal Haemorrhoids: A Systematic Review and Meta-Analysis.

Authors:  Minhtuan Nguyenhuy; Yifan Xu; Hong Kuan Kok; Julian Maingard; Shantanu Joglekar; Ashu Jhamb; Mark Brooks; Hamed Asadi
Journal:  Cardiovasc Intervent Radiol       Date:  2022-05-12       Impact factor: 2.797

3.  Safety and Effectiveness of a New Electrical Detachable Microcoil for Embolization of Hemorrhoidal Disease, November 2020-December 2021: Results of a Prospective Study.

Authors:  Miguel Angel De Gregorio; Román Bernal; Juan Jose Ciampi-Dopazo; José Urbano; Alfonso Millera; José Andres Guirola
Journal:  J Clin Med       Date:  2022-05-28       Impact factor: 4.964

4.  Polyherbal formulation Anoac‑H suppresses the expression of RANTES and VEGF for the management of bleeding hemorrhoids and fistula.

Authors:  Ashwin Porwal; Gopal C Kundu; Gajanan Bhagwat; Ramesh Butti
Journal:  Mol Med Rep       Date:  2021-08-20       Impact factor: 2.952

5.  Comparison of different embolic particles for superior rectal arterial embolization of chronic hemorrhoidal bleeding: gelfoam versus microparticle.

Authors:  Xuemin Wang; Yuguo Sheng; Zhu Wang; Wenming Wang; Fengfei Xia; Mengpeng Zhao; Xinqiang Han
Journal:  BMC Gastroenterol       Date:  2021-12-14       Impact factor: 3.067

6.  The Emborrhoid Technique for Treatment of Bleeding Hemorrhoids in Patients with High Surgical Risk.

Authors:  Paola Campennì; Roberto Iezzi; Angelo Alessandro Marra; Alessandro Posa; Angelo Parello; Francesco Litta; Veronica De Simone; Carlo Ratto
Journal:  J Clin Med       Date:  2022-09-21       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.